. "1"^^ . . "I" . "Kazuistiky v diabetologii" . "RIV/00216208:11120/10:00002777" . . . "Diabetes mellitus a karcinom pankreatu"@cs . "1"^^ . "Karcinom pankreatu je vysoce smrt\u00EDc\u00ED, pro radik\u00E1ln\u00ED l\u00E9\u010Dbu v\u011Bt\u0161inou pozd\u011B diagnostikovan\u00E9 onemocn\u011Bn\u00ED. Je p\u00E1tou nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou \u00FAmrt\u00ED u mu\u017E\u016F a \u0161estou nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou \u00FAmrt\u00ED u \u017Een %22z\u00E1padn\u00EDho sv\u011Bta%22 s medi\u00E1nem p\u0159e\u017Eit\u00ED m\u00E9n\u011B ne\u017E \u0161est m\u011Bs\u00EDc\u016F a p\u011Btilet\u00FDm p\u0159e\u017Eit\u00EDm pohybuj\u00EDc\u00EDm se mezi 1-4 %. Diabetes mellitus p\u0159edstavuje nez\u00E1visl\u00FD rizikov\u00FD faktor karcinomu pankreatu. V porovn\u00E1n\u00ED s nediabetiky je riziko karcinomu pankreatu u diabetes mellitus celkov\u011B dvakr\u00E1t vy\u0161\u0161\u00ED, osmkr\u00E1t vy\u0161\u0161\u00ED v prvn\u00EDch t\u0159ech letech onemocn\u011Bn\u00ED a jeden\u00E1ctkr\u00E1t vy\u0161\u0161\u00ED ve stejn\u00E9m obdob\u00ED, m\u00E1-li pacient nav\u00EDc pozitivn\u00ED rodinnou anamn\u00E9zu. Dal\u0161\u00EDm aditivn\u00EDm rizikov\u00FDm faktorem je kou\u0159en\u00ED. U pacient\u016F s diabetes mellitus by zejm\u00E9na p\u0159i jeho recentn\u00EDm z\u00E1chytu m\u011Blo b\u00FDt provedeno zobrazovac\u00ED vy\u0161et\u0159en\u00ED slinivky, pop\u0159\u00EDpad\u011B stanoven\u00ED onkomarker\u016F CA 19-9 a CEA. Na zv\u00FD\u0161en\u00E9 riziko karcinomu pankreatu by m\u011Blo b\u00FDt pom\u00FD\u0161leno i nad\u00E1le." . "Diabetes mellitus a karcinom pankreatu" . . "3"^^ . . . "Karcinom pankreatu je vysoce smrt\u00EDc\u00ED, pro radik\u00E1ln\u00ED l\u00E9\u010Dbu v\u011Bt\u0161inou pozd\u011B diagnostikovan\u00E9 onemocn\u011Bn\u00ED. Je p\u00E1tou nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou \u00FAmrt\u00ED u mu\u017E\u016F a \u0161estou nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou \u00FAmrt\u00ED u \u017Een %22z\u00E1padn\u00EDho sv\u011Bta%22 s medi\u00E1nem p\u0159e\u017Eit\u00ED m\u00E9n\u011B ne\u017E \u0161est m\u011Bs\u00EDc\u016F a p\u011Btilet\u00FDm p\u0159e\u017Eit\u00EDm pohybuj\u00EDc\u00EDm se mezi 1-4 %. Diabetes mellitus p\u0159edstavuje nez\u00E1visl\u00FD rizikov\u00FD faktor karcinomu pankreatu. V porovn\u00E1n\u00ED s nediabetiky je riziko karcinomu pankreatu u diabetes mellitus celkov\u011B dvakr\u00E1t vy\u0161\u0161\u00ED, osmkr\u00E1t vy\u0161\u0161\u00ED v prvn\u00EDch t\u0159ech letech onemocn\u011Bn\u00ED a jeden\u00E1ctkr\u00E1t vy\u0161\u0161\u00ED ve stejn\u00E9m obdob\u00ED, m\u00E1-li pacient nav\u00EDc pozitivn\u00ED rodinnou anamn\u00E9zu. Dal\u0161\u00EDm aditivn\u00EDm rizikov\u00FDm faktorem je kou\u0159en\u00ED. U pacient\u016F s diabetes mellitus by zejm\u00E9na p\u0159i jeho recentn\u00EDm z\u00E1chytu m\u011Blo b\u00FDt provedeno zobrazovac\u00ED vy\u0161et\u0159en\u00ED slinivky, pop\u0159\u00EDpad\u011B stanoven\u00ED onkomarker\u016F CA 19-9 a CEA. Na zv\u00FD\u0161en\u00E9 riziko karcinomu pankreatu by m\u011Blo b\u00FDt pom\u00FD\u0161leno i nad\u00E1le."@cs . "CZ - \u010Cesk\u00E1 republika" . "Diabetes mellitus a karcinom pankreatu"@cs . "1214-231X" . "Diabetes mellitus and pancreatic cancer"@en . . "11120" . . . "254064" . "Pancreatic cancer is a highly lethal disease, which is in most cases diagnosed too late to be treated radically. It is the fifth leading cause of death in men and the sixth leading cause of death in women in the %22western world%22, with median survival shorter than six months and five-year survival between 1-4 %. Diabetes mellitus is an independent risk factor of pancreatic cancer. Diabetes mellitus increases the total risk of pancreatic cancer twofold compared to non-diabetic population, eightfold during the first three years of the disease and elevenfold during the same period in patients with a positive familiar history. Smoking is the additional independent risk factor. In patients with diabetes mellitus the imaging examination of pancreas should be performed, especially in recent diagnosis; or the oncomarkers CA 19-9 and CEA should be measured. The higher risk of pancreatic cancer should be continuously taken into account."@en . . "RIV/00216208:11120/10:00002777!RIV11-MSM-11120___" . . "pancreatic cancer; diabetes mellitus; IGF-1; CEA; CA 19-9"@en . . "Bro\u017E, Jan" . . "4" . "[6B1F6655251C]" . "Diabetes mellitus a karcinom pankreatu" . "8" . . . "Diabetes mellitus and pancreatic cancer"@en .